United States, Sept. 9 -- GE HealthCare in collaboration with the University of Oklahoma (OU) and Cyclomedical International, announced a new cyclotron to be installed at the OU Health campus, marking a transformative step forward in precision medicine, theranostics, and radiopharmaceutical innovation in the region.The GE HealthCare PETtrace 890 cyclotron will enable on-site production of radiotracers - the radioactive compounds essential for PET imaging and theranostic applications - for diagnosis of serious conditions including cancer and heart disease, and evaluation of neurodegenerative diseases including Alzheimer's.The cyclotron uses powerful particle acceleration to nearly one-fifth the speed of light to ultimately produce radiotrace...